Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Wolbachia endosymbiont of Brugia malayi | peptide deformylase | 0.0225 | 1 | 0.5 |
Treponema pallidum | polypeptide deformylase (def) | 0.0225 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0167 | 0 | 0.5 |
Mycobacterium ulcerans | peptide deformylase | 0.0225 | 1 | 0.5 |
Mycobacterium leprae | PROBABLE POLYPEPTIDE DEFORMYLASE DEF (PDF) (FORMYLMETHIONINE DEFORMYLASE) | 0.0225 | 1 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0167 | 0 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0225 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable polypeptide deformylase Def (PDF) (formylmethionine deformylase) | 0.0225 | 1 | 0.5 |
Plasmodium vivax | peptide deformylase, putative | 0.0225 | 1 | 0.5 |
Plasmodium falciparum | peptide deformylase | 0.0225 | 1 | 0.5 |
Echinococcus granulosus | geminin | 0.0167 | 0 | 0.5 |
Echinococcus multilocularis | geminin | 0.0167 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.